文献速递母胎医学产科

安大略省公共资助无细胞DNA筛查的两年回顾:利用情况与资助标准依从性

A 2-year review of publicly funded cell-free DNA screening in Ontario: utilization and adherence to funding criteria.
PubMed 文献 · Prenat Diagn · 2019-11-21

该研究为描述性队列研究,利用安大略省母婴登记数据,纳入2016年1月至2017年12月所有接受cfDNA筛查的孕妇,审查公共资助cfDNA筛查的利用情况及对资助标准的依从性。结果显示最常见资助标准为高龄≥40岁(37.7%)、多重标志物筛查阳性(34.1%)等;2.9%的资助cfDNA筛查不符合资助标准,11.4%的自费cfDNA筛查本可公共资助。结论认为审计有助于识别需针对性教育的领域并重新评估资助模式。

要点

  • 公共资助cfDNA筛查最常见标准为高龄≥40岁(37.7%)和多重标志物筛查阳性(34.1%)。
  • 2.9%的资助cfDNA筛查不符合资助标准,11.4%的自费cfDNA筛查本可公共资助。
  • 利用登记数据审计资助标准应用,可识别需针对性教育以改善依从性的领域。

核心结论

  • 审查和审计资助cfDNA筛查标准应用可识别针对性教育机会,并为重新评估资助模式提供依据。

研究设计与样本

  • 描述性队列研究,使用安大略省处方母婴登记数据,纳入2016年1月至2017年12月所有接受cfDNA筛查的孕妇。

主要发现

  • 公共资助cfDNA筛查最常见标准为高龄≥40岁(37.7%)、多重标志物筛查阳性(34.1%)、超声软指标等修正风险因素(7.1%)及既往非整倍体(5.5%)。
  • 2.9%的资助cfDNA筛查不符合资助标准,11.4%的自费cfDNA筛查本可公共资助。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ontario offers a publicly funded modified contingent model of prenatal screening for aneuploidy in which cell-free DNA (cfDNA) screening is covered for pregnancies at higher risk of fetal aneuploidy. The objective of this study was to review utilization of provincially funded cfDNA screening and adherence to the criteria laid out in Ontario prenatal screening guidelines. METHODS: This was a descriptive cohort study using data collected by Ontario's prescribed maternal and child registry. The study population included all pregnant individuals who received cfDNA screening from January 2016 to December 2017. RESULTS: The most common criteria for provincially funded cfDNA screening were advanced maternal age ≥40 years (37.7%), positive multiple marker screen (34.1%), modifying risk factors such as ultrasound soft markers (7.1%), and previous aneuploidy (5.5%). The audit demonstrated that 2.9% of funded cfDNA screens tests did not meet funding criteria, and that 11.4% of self-paid cfDNA screens could have been publicly funded. CONCLUSION: Reviewing and auditing the application of criteria for funded cfDNA screening using prescribed registry data allows an opportunity to identify areas where targeted education may improve adherence to standardized screening protocols, and provides a basis for reassessment of the funding model.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Bellai-Dussault K, Meng L, Huang T, et al. A 2-year review of publicly funded cell-free DNA screening in Ontario: utilization and adherence to funding criteria. Prenat Diagn. 2019. PMID: 31525278. doi:10.1002/pd.5563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。